About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT04372355

Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients

Study in adult Diabetes Mellitus patients with diabetic foot ulcers and elevated HbA1c who will receive standard wound treatment in combination with adjuvant therapy WF10 to compare the change of HbA1...

Lead sponsor: Srinakharinwirot University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Srinakharinwirot University

Collaborators

Oxo Chemie(Thailand) Co.,Ltd.
Altermed Co.,Ltd.

Single-center, Prospective Open-labelled One Group Pretest Posttest Pilot Study

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients diagnosed with Diabetes Mellitus type II
•Patient male or female 18-80 years old
•Presence of Diabetic foot ulcer/non-healed stump, starting at least 3 weeks before or infected wound degree 3-4
•HbA1c \> 8.5%
•Hematocrit \> 30%

Exclusion Criteria

•Kanofsky performance status \< 60
•Patient with ABI (Ankle Brachial index) \< 0.4
•Patient who receive steroid ,chemotherapeutic drug
•Pregnant or lactating woman
•Patient had a history of organ transplantation, and using immunosuppressive drug
•Patient with end-stage renal disease requiring hemodialysis, or history of G6PD or severe thalassemia, or ischemic heart disease, Congestive heart failure, Heart arrhythmia
•Patient who is participating in another clinical study or have done it in the past 30 days.

Related studies

PAW-Hydrogel for Chronic Wound Healing

NCT07541196 · Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU), and more

Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs

NCT06449638 · Diabetic Foot Ulcer (DFU), Ulcer Foot, and more

Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers

NCT07116876 · Diabetic Foot Ulcer (DFU), Lower Extremity

CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations

NCT07046767 · Diabetic Foot Ulcer (DFU), Venous Leg Ulcer, and more

CARE-D-FOOT-Nav Pilot

NCT07143175 · Diabetic Foot Ulcer (DFU)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 22, 2020Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment40

Start dateJun 2019

Last updatedOct 22, 2020

Condition

Diabetic Foot Ulcer (DFU)Uncontrolled Diabetes With Foot Ulcer

Locations shown

HRH Princess Maha Chakri Sirindhorm Medical Center

Ongkharak, Changwat Nakhon Nayok

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 22, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions